Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Chromosomal differences affect how muscle cells respond to testosterone.

The herbal mixture could potentially improve hair loss.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

The spironolactone cream did not reduce hair growth in women with hirsutism.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Androgens affect skin conditions like acne and hair loss through specific biochemical pathways.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Testosterone raises blood pressure and changes kidney protein levels.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Finasteride, originally for prostate issues, also treats hair loss, similar to effects from certain plants.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The FG score is better at detecting hyperandrogenism in PCOS patients than testosterone levels or FAI, but testosterone is the recommended test for diagnosis.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Testosterone helps beard and axillary hair cells grow by releasing growth factors from dermal papilla cells.